Events

Developing A Novel Single Dose Nasal Delivery System

Online, Webinar

26 April 2023

Event details

Clinical Operations In Oncology Trials West Coast 2023

San Francisco, CA, USA

25 - 26 April 2023

Event details

Clinical Trial Supply West Coast 2023

Burlingame, CA, USA

9- 10 May 2023

Event details

Outsourcing In Clinical Trials Europe 2023

Barcelona, Spain

3 - 4 May 2023

Event details

Outsourcing In Clinical Trials East Coast 2023

King of Prussia, PA, USA

23 - 24 May 2023

Event details

Clinical Operations In Oncology Trials East Coast 2023

Burlington, MA, USA

11 - 12 July 2023

Event details

Clinical Data Management Innovation 2023

Princeton, NJ, USA

13 - 14 September 2023

Event details

Outsourcing In Clinical Trials UK And Ireland 2023

London, UK

5 - 6 September 2023

Event details

Outsourcing In Clinical Trials Southern California 2023

San Diego, CA, USA

26 - 27 September 2023

Event details

Clinical Trial Supply East Coast 2023

King of Prussia, PA, USA

11 - 12 October 2023

Event details

Clinical Trial Supply Nordics 2023

Copenhagen, Denmark

24 - 25 October 2023

Event details

Outsourcing In Clinical Trials New England 2023

Boston, MA, USA

1 - 2 November 2023

Event details

Outsourcing In Clinical Trials Pacific Northwest 2023

Seattle, WA, USA

8 - 9 November 2023

Event details

Outsourcing In Clinical Trials DACH 2023

Zurich, Switzerland

21 - 22 November 2023

Event details

Clinical Operations In Oncology Trials Europe 2023

Munich, Germany

28 - 29 November 2023

Event details

Go to article: Home | Nanoparticle drug delivery research gets a boostGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: NiproGo to article: In DepthGo to article: Covid-19 vaccine success bolsters nanoparticle drug delivery research Go to article: eConsent in clinical trials: What’s on the horizon?Go to article: Breathing easy: How digital inhalers are changing asthma treatmentGo to article: Primate models in pharma: What the future holds Go to article: A decade on, what’s next for CAR-T therapies?Go to article: FDA’s $7bn plan for 2024: Disclose CMOs, restart Cancer MoonshotGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: ESG is the most important theme of this decadeGo to article: A timeline of corporate ESGGo to article: The most pressing ESG concerns for the pharma industryGo to article: Key trends impacting ESG performance in the healthcare sectorGo to article: Latest news: ESG in pharmaGo to article: Sustainable supply chains: Clinical trials in a new era of limited resourcesGo to article: Increase in DPI use could lead to decreases in greenhouse gas emissionsGo to article: Environmental sustainability innovation: Leading companies in anti-malarial compositionsGo to article: Deal activity related to ESG in the pharmaceutical industry since 2020Go to article: ESG hiring trends in the global pharmaceutical industry since 2020Go to article: ESG patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of ESG in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Pharma Sponsored SupplementsGo to article: CfPIEGo to article: ListingsGo to article: EventsGo to article: RankingsGo to article: Buyer's GuidesGo to article: Next issue